Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Terminated × abemaciclib × Clear all

Phase

Phase 2 8 Phase 1 3 Phase 3 2 Phase 1/2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1

Status

Withdrawn 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6 Cyclophosphamide 6 pembrolizumab 4 Nivolumab 4 Fluorouracil 4 Carboplatin 4 Biopsy 4 X-Rays 3 Vincristine 3 Radiosurgery 3 Positron-Emission Tomography 3 Cisplatin 3 Bevacizumab 3 fludarabine phosphate 2 durvalumab 2 atezolizumab 2 Topotecan 2 Taxes 2 Surveys and Questionnaires 2 Specimen Handling 2 Rituximab 2 Radiotherapy 2 Oxaliplatin 2 Metformin 2 Leucovorin 2 Letrozole 2 Lapatinib 2 Ketoconazole 2 Ketamine 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04074785 2025-08-17

SCCC-06319

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Terminated

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡